Citations

Mayo Clinic

Showing 10 of 108551 citations.

Design and Development of a Powered Myoelectric Elbow Orthosis for Neuromuscular Injuries
Vignola, Claudio, Bhat, Sandesh G. , Hollander, Kevin W., Kane, Paul H., Miller, Emily J. , Martin, W. Brandon , Shin, Alexander Y. , Sugar, Thomas G. , Kane, Paul, Miller, Emily , Kaufman, Kenton R , Shin, Alexander Y , Bhat, Sandesh G , Kaufman, Kenton R.

Military Medicine | April 3, 2024 | Volume: 189 | Issue: Supplement_3 | Pages: 585-591

10.1093/milmed/usae196 | PMID 39160856 Get It

ABSTRACT Introduction Recovering from neuromuscular injuries or conditions can be a challenging journey that involves complex surgeries and extensive physical rehabilitation. During this process, individuals often rely on orthotic devices to support and enable movement of the affected limb. However, users have criticized current commercially available powered orthotic devices for their bulky and heavy design. To address these limitations, we developed a novel powered myoelectric elbow orthosis. Materials and Methods The orthosis incorporates 3 mechanisms: a solenoid brake, a Bowden cable-powered constant torque elbow mechanism, and an extension limiter. The device controller and battery are in a backpack to reduce the weight on the affected arm. We performed extensive calculations and testing to ensure that the orthosis could withstand at least 15 Nm of elbow torque. We developed a custom software effectively control the orthosis, enhancing its usability and functionality. A certified orthotist fitted a subject who had undergone a gracilis free functioning muscle transfer surgery with the device. We studied the subject under Mayo clinic IRB no. 20-006849 and obtained objective measurements to assess the orthosis’s impact on upper extremity functionality during daily activities. Results The results are promising since the orthosis significantly improved elbow flexion range of motion by 40° and reduced compensatory movements at the shoulder (humerothoracic joint) by 50°. Additionally, the subject was able to perform tasks which were not possible before, such as carrying a basket with weights, highlighting the enhanced functionality provided by the orthosis. Conclusion In brief, by addressing the limitations of existing devices, this novel powered myoelectric elbow orthosis offers individuals with neuromuscular injuries/conditions improved quality of life. Further research will expand the patient population and control mechanisms.
Effect of Oscillation and Pulmonary Expansion Therapy on Pulmonary Outcomes after Cardiac Surgery
Williams, Christopher D. , Holbrook, Kirsten M., Shiari, Aryan , Zaied, Ali, Al‐Sharif, Hussam, Frank, Ryan D. , Zurob, Adel , Rishi, Muhammad Adeel , Rishi, Muhammad A , Shiari, Aryan , Rishi, Abdul

Journal of Respiration | April 3, 2024 | Volume: 4 | Issue: 2 | Pages: 91-101

10.3390/jor4020008 Get It

Background: Oscillation and pulmonary expansion (OPE) therapy can decrease postoperative pulmonary complications in a general surgical population, but its effect after cardiac surgery has not been reported, to our knowledge. We hypothesized that using an OPE device after cardiac surgery before extubation would decrease pulmonary complications. Methods: This retrospective cohort study included adults undergoing elective open cardiac surgery at our institution from January 2018 through January 2019, who had an American Society of Anesthesiologists score of 3 or greater. For mechanically ventilated patients after cardiac surgery, a new OPE protocol was adopted, comprising an initial 10-min OPE treatment administered in-line with the ventilator circuit, then continued treatments for 48 h after extubation. The primary outcome measure was the occurrence of severe postoperative respiratory complications, including the need for antibiotics, increased use of supplemental oxygen, and prolonged hospital length of stay (LOS). Demographic, clinical, and outcome data were compared between patients receiving usual care (involving post-extubation hyperinflation) and those treated under the new OPE protocol. The primary outcome measure was the occurrence of severe postoperative respiratory complications, including the need for antibiotics, increased use of supplemental oxygen, and prolonged hospital length of stay (LOS). Demographic, clinical, and outcome data were compared between patients receiving usual care (involving post-extubation hyperinflation) and those treated under the new OPE protocol. Results: Of 104 patients, 54 patients received usual care, and 50 received OPE. Usual-care recipients had more men (74% vs. 62%; p = 0.19) and were older (median, 70 vs. 67 years; p = 0.009) than OPE recipients. The OPE group had a significantly shorter hospital LOS than the usual-care group (mean, 6.2 vs. 7.4 days; p = 0.04). Other measures improved with OPE but did not reach significance: shorter ventilator duration (mean, 0.6 vs. 1.1 days with usual care; p = 0.06) and shorter LOS in the intensive care unit (mean, 2.7 vs. 3.4 days; p = 0.06). On multivariate analysis, intensive care unit LOS was significantly shorter for the OPE group (mean difference, −0.85 days; 95% CI, −1.65 to −0.06; p = 0.04). The OPE group had a lower percentage of postoperative complications (10% vs. 20%). Conclusions: OPE therapy after cardiac surgery is associated with decreased intensive care unit (ICU) and hospital LOS.
Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity
Desai, Aakash , Hashash, Jana G. , Farraye, Francis A. , Regueiro, Miguel , Kochhar, Gursimran , Hashash, Jana G , Farraye, Francis A , Regueiro, Miguel , Desai, Aakash , Khataniar, Himsikhar

Inflammatory Bowel Diseases | April 3, 2024 | Volume: 31 | Issue: 3 | Pages: 696-705

10.1093/ibd/izae090 | PMID 38642103 Get It

Abstract Background Semaglutide, a glucagon-like peptide-1 receptor agonist, has shown sustained and clinically significant weight loss in the general population. There are limited data on outcomes of its use in patients with inflammatory bowel disease (IBD). Methods A retrospective cohort study was conducted between June 4, 2021, and December 11, 2023, using TriNetX, a U.S. multi-institutional database in patients with obesity who had IBD compared with patients without IBD. The primary aim was to assess the mean total body weight (TBW) change between 6 and 15 months from initiation of semaglutide compared with baseline between the 2 cohorts. One-to-one (1:1) propensity score matching was performed for demographics, comorbid conditions, smoking status, and mean body mass index. A 2-sample t test was performed to assess mean TBW change from baseline, with a P value <.05 considered to be statistically significant. We also compared the risk of IBD-specific outcomes with and without semaglutide use in patients with IBD. Results Out of 47 424 patients with IBD and obesity, 150 (0.3%) patients were prescribed semaglutide (mean age 47.4 ± 12.2 years; mean TBW 237 ± 54.8 pounds; mean body mass index 36.9 ± 6.5 kg/m2; 66% Crohn’s disease). There was no difference in mean TBW change after initiation of semaglutide in the IBD and non-IBD cohorts (−16 ± 13.4 pounds vs −18 ± 12.7 pounds; P = .24). There was no difference in mean TBW change between 6 and 12 months (−16 ± 13 pounds vs −15 ± 11.2 pounds; P = .24) and 12 and 15 months (−20 ± 13.2 pounds vs −21 ± 15.3 pounds; P = .49) between the 2 cohorts. There was no difference in the risk of oral or intravenous steroid use and any-cause hospitalization in the semaglutide group compared with the group without semaglutide use in patients with IBD. Conclusion Semaglutide use is effective in patients with IBD and obesity similar to patients without IBD, with >5% mean weight loss. There was no increased risk of IBD-specific adverse events with semaglutide use.
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology
Rahman, Rifaquat , Haas‐Kogan, Daphne A. , D’Andrea, Alan D. , Tanner, Kirk, Agar, Nathalie Y.R. , Wen, Patrick Y. , Wen, Patrick Yung , Agar, Nathalie Y R , D'Andrea, Alan , Shi, Diana D. , Reitman, Zachary J. , Hamerlik, Petra , Groot, John de , Sulman, Erik P. , Sarkaria, Jann N. , Tinkle, Christopher L , Bindra, Ranjit S. , Mehta, Minesh P.

Neuro-Oncology | April 3, 2024 | Volume: 26 | Issue: 8 | Pages: 1367-1387

10.1093/neuonc/noae072 | PMID 38770568 Get It

Abstract DNA damage response (DDR) mechanisms are critical to maintenance of overall genomic stability, and their dysfunction can contribute to oncogenesis. Significant advances in our understanding of DDR pathways have raised the possibility of developing therapies that exploit these processes. In this expert-driven consensus review, we examine mechanisms of response to DNA damage, progress in development of DDR inhibitors in IDH-wild-type glioblastoma and IDH-mutant gliomas, and other important considerations such as biomarker development, preclinical models, combination therapies, mechanisms of resistance and clinical trial design considerations.
Social relationships, amyloid burden, and dementia: The ARIC‐PET study
Groechel, Renée C. , Liu, Albert C. , Koton, Silvia , Kucharska‐Newton, Anna , Lutsey, Pamela L. , Palta, Priya, Sharrett, A. Richey , Wong, Dean F. , Lutsey, Pamela L , Kucharska-Newton, Anna M , Liu, Chelsea , Knopman, David S. , Mosley, Thomas H. , Walker, Keenan A. , Gottesman, Rebecca F.

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | April 3, 2024 | Volume: 16 | Issue: 2 | Pages: No page available

10.1002/dad2.12560 | PMID 38571965 Get It

AbstractINTRODUCTIONThis study aimed to assess whether social relationships in mid‐life reduce the risk of dementia related to amyloid burden.METHODSParticipants in the Atherosclerosis Risk in Communities (ARIC) study were assessed for social support and isolation (visit 2; 1990–1992). A composite measure, “social relationships,” was generated. Brain amyloid was evaluated with florbetapir positron emission tomography (PET); (visit 5; 2012–2014). Incident dementia cases were identified following visit 5 through 2019 using ongoing surveillance. Relative contributions of mid‐life social relationships and elevated brain amyloid to incident dementia were evaluated with Cox regression models.RESULTSAmong 310 participants without dementia, strong mid‐life social relationships were associated independently with lower dementia risk. Elevated late‐life brain amyloid was associated with greater dementia risk.DISCUSSIONAlthough mid‐life social relationships did not moderate the relationship between amyloid burden and dementia, these findings affirm the importance of strong social relationships as a potentially protective factor against dementia.
Commentary on Severe Hypokalaemia Associated with Paralysis after a Large Carbohydrate Intake following Exercise
Grebe, Stefan K. , Grebe, Stefan K G

Clinical Chemistry | April 3, 2024 | Volume: 70 | Issue: 4 | Pages: 587-587

10.1093/clinchem/hvad229 | PMID 38565210 Get It

Surgical Approaches to Resection of Olfactory Groove Meningiomas: Comparative Meta-analysis of the Endoscopic Endonasal versus Transcranial and Unilateral versus Bilateral Approaches
Brown, Nolan J. , Pennington, Zach , Patel, Saarang, Kuo, Cathleen C. , Chakravarti, Sachiv , Bui, Nicholas, Gendreau, Julian , Gompel, Jamie J. Van , Van Gompel, Jamie J , Pennington, Zach , Patel, Saarang

Journal of Neurological Surgery Part B: Skull Base | April 2, 2024 | Volume: 86 | Issue: 02 | Pages: 208-220

10.1055/a-2297-9055 | PMID 40104542 Get It

Abstract Introduction Here we systematically review the extant literature to highlight the advantages of bilateral versus unilateral approaches and endoscopic endonasal (midline) approaches versus transcranial approaches for olfactory groove meningiomas, focusing on complications, extent of resection, and local recurrence rates. Methods Three databases were queried to identify all primary prospective trials and retrospective series comparing outcomes following endoscopic endonasal versus transcranial approaches and unilateral versus bilateral craniotomy for surgical resection of olfactory groove meningiomas. All articles were screened by two independent authors and selected for formal analysis according to predefined inclusion/exclusion criteria. Results Seven studies comprising 288 total patients (mean age 55.0 ± 24.6 years) met criteria for inclusion. In the three comparing the endoscopic endonasal (n = 21) versus transcranial (n = 32) approaches, there was no significant difference between the two with respect to gross total resection (p = 0.34) or rates of Simpson Grade 1 resection (p = 0.69). EEA demonstrated higher rates of overall complications (p < 0.01) including postoperative infection (p = 0.03). In the four studies comparing bilateral (n = 117) versus unilateral approaches (n = 118), overall complication rates (p < 0.01) and disease recurrence (p = 0.01) were higher with bilateral approaches. All surgery-related mortalities also occurred in the bilateral cohort (n = 7, 7.14%). Gross total resection (p = 0.63) and Simpson grade (p = 0.48) were comparable between approaches. Olfaction preservation was superior for unilateral approaches (p < 0.01). Conclusion Though the literature is limited, current evidence suggests that the endoscopic endonasal approach may be favorable over conventional craniotomy for select olfactory groove meningioma patients. Where craniotomy is used, unilateral approaches appear to reduce complications and the risk of olfaction loss.
Factors Affecting Performance on a Screening Tool in Persons with Amyotrophic Lateral Sclerosis
Stierwalt, Jordan, Stierwalt, Julie A. G., Burda, Angela N. , Kiley, Hanna Benavidez, Collins, Erica, Kortemeyer, Morgan, Peckenschneider, Grace, Schieltz, Elizabeth K., Shah, Yashvi , Simon, Kayleigh, Clark, Heather, Clark, Heather M. , Collins, Erica, Miller, Elizabeth, Shah, Yashvi

Seminars in Speech and Language | April 2, 2024 | Volume: 45 | Issue: 03 | Pages: 228-241

10.1055/s-0044-1785447 | PMID 38565200 Get It

AbstractPersons with amyotrophic lateral sclerosis (PALS) are at risk of developing cognitive impairments and frontotemporal dementia (FTD). This study examined the relationship between performance of the ALS-Cognitive Behavioral Screen (ALS-CBS) and the demographic parameters of sex, education, time post–ALS diagnosis, and severity of symptoms. Data were collected retrospectively from 69 participants seen at the Mayo Clinic. Correlations were conducted on the ALS-CBS total scores and subsection scores and the above listed parameters; t-tests were conducted between participant subgroups. No statistically significant relationships or differences occurred between the ALS-CBS or its subsections and the variables measured with exception of age and the attention subsection. Older participants had lower ALS-CBS attention subsection scores. Based on the ALS-CBS scores, most participants had some degree of cognitive impairments: 43 had suspected cognitive impairment, 8 had suspected FTD; 18 fell within the normal range of cognitive function. Overall, the variables of sex, education, time post-diagnosis, and severity of symptoms do not appear to influence ALS-CBS scores. It is recommended cognitive screenings be completed for all PALS due to the high risk for developing cognitive impairments and FTD. Such knowledge can help clinicians develop assessment and treatment plans.
Diagnosing Smoldering Multiple Myeloma and Light Chain Amyloidosis in the Setting of Severe Transthyretin Amyloid Cardiomyopathy and Extracardiac Sarcoidosis
Churchill, Robert , Rosenbaum, Andrew , Churchill, Robert A

Annals of Internal Medicine: Clinical Cases | April 2, 2024 | Volume: 3 | Issue: 4 | Pages: No page available

10.7326/aimcc.2023.1117 Get It

The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance
Li, Marissa , Baranwal, Anmol , Gurney, Mark E. , Shah, Syed Nasir Ali, Al‐Kali, Aref , Foran, James M. , Yi, Cecilia Arana , Ongie, Laura , Mangaonkar, Abhishek A. , Tefferi, Ayalew , Lasho, Terra, Finke, Christy M. , Patnaik, Mrinal M. , Gurney, Mark , Shah, Syed N, Arana Yi, Cecilia , McCullough, Kristen B , Patnaik, Mrinal , Shah, Mithun V , Baranwal, Anmol , Li, Marissa M , Alkhateeb, Hassan B. , Chen, Dong , McCullough, Kristen , Lasho, Terra, Shah, Meera

Blood Advances | April 2, 2024 | Volume: 8 | Issue: 12 | Pages: 3130-3139

10.1182/bloodadvances.2023012357 | PMID 38564774 Get It

Abstract Clonal cytopenia of undetermined significance (CCUS) is defined by a myeloid driver mutation in the context of otherwise unexplained cytopenia. CCUS has an inherent risk of progressing to myeloid neoplasm. However, it is unknown how exposure to previous cytotoxic therapy may impact the risk of progression and survival. We stratified patients with CCUS by prior exposure to DNA-damaging therapy. Of 151 patients, 46 (30%) had received cytotoxic therapy and were classified as therapy-related CCUS (t-CCUS), whereas 105 (70%) had de novo CCUS. A lower proportion of t-CCUS had hypercellular marrows (17.8% vs 44.8%, P = .002) but had higher median bone marrow blast percentages. After a median follow-up of 2.2 years, t-CCUS had significantly shorter progression-free survival (PFS, 1.8 vs 6.3 years; hazard ratio [HR], 2.1; P = .007) and median overall survival (OS; 3.6 years vs not reached; HR, 2.3; P = .007) compared with CCUS. Univariable and multivariable time-to-event analyses showed that exposure to cytotoxic therapy independently accounted for inferior PFS and OS. Despite the similarities in clinical presentation between CCUS and t-CCUS, we show that exposure to prior cytotoxic therapies was an independent risk factor for inferior outcomes. This suggests that t-CCUS represents a unique clinical entity that needs more stringent monitoring or earlier intervention strategies.